The introduction of p53 did not influence MCB1 overexpressing‐reduced cell apoptosis upon targeted drugs (Figure S8A, Supporting Information), suggesting that MCB1 limits the response of HCC cells to targeted drugs through a p53‐independent mechanism. This evidence concerns the gene TP53 and hepatocellular carcinoma.